Preferentially expressed antigen of melanoma
RxNorm 2609615
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2609615 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Preferentially expressed antigen of melanoma.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Melanoma antigen preferentially expressed in tumors
(Atom ID: 12756308)
FN
Full form of descriptor (FN):
Melanoma antigen preferentially expressed in tumors (substance)
(Atom ID: 12756309)
PTGB
British preferred term (PTGB):
Melanoma antigen preferentially expressed in tumours
(Atom ID: 12756310)
SY